Trials / Recruiting
RecruitingNCT06474884
The Safety and Efficacy of Single Antiplatelet Therapy After Pipeline Flex with Shield for Intracranial Aneurysms
A Single-center, Prospective, Cohort Study of the Safety and Efficacy of Single Antiplatelet Therapy After Pipeline Flex with Shield Stent Implantation for Intracranial Aneurysms
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 165 (estimated)
- Sponsor
- Xuanwu Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to evaluate the safety and efficacy of single antiplatelet therapy after Pipeline flex with Shield stent implantation for intracranial aneurysms.
Detailed description
Title：A single-center, prospective, cohort study of the safety and efficacy of Single Antiplatelet therapy after Pipeline flex with Shield stent implantation for intracranial aneurysms. Purpose：To assess the safety and efficacy of single antiplatelet therapy after Pipeline flex with Shield stent implantation for intracranial aneurysms. Follow up:The follow-up period was 6 months.
Conditions
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-12-30
- Completion
- 2025-12-30
- First posted
- 2024-06-26
- Last updated
- 2024-12-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06474884. Inclusion in this directory is not an endorsement.